Your browser doesn't support javascript.
loading
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques.
Rosati, Margherita; Agarwal, Mahesh; Hu, Xintao; Devasundaram, Santhi; Stellas, Dimitris; Chowdhury, Bhabadeb; Bear, Jenifer; Burns, Robert; Donohue, Duncan; Pessaint, Laurent; Andersen, Hanne; Lewis, Mark G; Terpos, Evangelos; Dimopoulos, Meletios Athanasios; Wlodawer, Alexander; Mullins, James I; Venzon, David J; Pavlakis, George N; Felber, Barbara K.
Afiliação
  • Rosati M; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Agarwal M; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Hu X; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Devasundaram S; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Stellas D; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Chowdhury B; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Bear J; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Burns R; Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, Maryland, United States of America.
  • Donohue D; MS Applied Information and Management Sciences, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Pessaint L; BIOQUAL, Inc.; Rockville, Maryland, United States of America.
  • Andersen H; BIOQUAL, Inc.; Rockville, Maryland, United States of America.
  • Lewis MG; BIOQUAL, Inc.; Rockville, Maryland, United States of America.
  • Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Wlodawer A; Center for Structural Biology, National Cancer Institute, Frederick, Maryland, United States of America.
  • Mullins JI; Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
  • Venzon DJ; Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Pavlakis GN; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
  • Felber BK; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS Pathog ; 17(9): e1009701, 2021 09.
Article em En | MEDLINE | ID: mdl-34551020

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas de DNA / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / Macaca mulatta Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas de DNA / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / Macaca mulatta Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article